Enliven Therapeutics, Inc.
Industry: Life Sciences ・ $ELVN on Nasdaq
Insider Sale
+$281,911
-0.95%
Shares
Shares Volume: 10,229 Shares
Average Share Price: $27.56
INSIDER
Lyssikatos Joseph P
CHIEF SCIENTIFIC OFFICER (Officer)
reported on Oct 8 2024
traded on Oct 4 2024
TRADE ACTIVITY 1Y
current insider trade in blue
INSIDER ACTIVITY
| NEW SHARES OWNERSHIP AMOUNT | 1,067,180 |
| PURCHASES/SALES 1Y | 0 / 16 |
| P/S VALUE RATIO | N/A |
| AVERAGE SALE VALUE | $224,302.67 |
| INSIDER PREVIOUS TRADES |
COMPANY OVERALL ACTIVITY
INSIDERS IN PAST 2 WEEKS with at least one purchase / sale | 0 / 4 |
| PURCHASES/SALES 1Y | 0 / 89 |
| P/S VALUE RATIO | N/A |
| AVERAGE SALE VALUE | $901,909.01 |
| COMPANY PREVIOUS TRADES |